Virios Therapeutics Inc. (NASDAQ: VIRI) is 467.80% higher on its value in year-to-date trading and has touched a low of $0.22 and a high of $9.11 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VIRI stock was last observed hovering at around $1.23 in the last trading session, with the day’s gains setting it 0.11% off its average median price target of $12.00 for the next 12 months. It is also 88.83% off the consensus price target high of $12.00 offered by 1 analysts, but current levels are 88.83% higher than the price target low of $12.00 for the same period.
Currently trading at $1.34, the stock is 35.22% and 97.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.68 million and changing 8.94% at the moment leaves the stock -4.42% off its SMA200. VIRI registered -69.61% loss for a year compared to 6-month gain of 327.02%. The firm has a 200-day simple moving average (SMA200) of -$1.20.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The stock witnessed a 38.14% loss in the last 1 month and extending the period to 3 months gives it a 318.75%, and is 28.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.83% over the week and 13.59% over the month.
Distance from 52-week low is 512.01% and -85.29% from its 52-week high.
Virios Therapeutics Inc. (VIRI) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Virios Therapeutics Inc. (VIRI) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Virios Therapeutics Inc. is expected to release its quarterly report on 08/10/2023.The EPS is expected to grow by 42.30% this year
Virios Therapeutics Inc. (VIRI) Top Institutional Holders
The shares outstanding are 18.33M, and float is at 16.08M with Short Float at 6.52%.
Virios Therapeutics Inc. (VIRI) Insider Activity
A total of 2 insider transactions have happened at Virios Therapeutics Inc. (VIRI) in the last six months, with sales accounting for 1 and purchases happening 1 times. The most recent transaction is an insider sale by Whitley Richard James, the company’s Director. SEC filings show that Whitley Richard James sold 1,800 shares of the company’s common stock on Dec 08 at a price of $0.26 per share for a total of $466.0. Following the sale, the insider now owns 700.0 shares.
